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ABSTRACT
Objective: Congenital cytomegalovirus (CMV) infection is a leading cause of hearing loss and
mental retardation throughout the. world. Detection of the CMV DNA by polymerase chain reac-
tion (PCR) offers a sensitive, rapid, and specific means of identification. Meconium, the stool
formed in utero, may be an ideal specimen for CMV detection. The objective of this study was to
develop a PCR-based methodology for the detection ofCMV in the meconium of neonates.
Methods: Meconium was collected from 10 newborn infants (seven with positive viral cultures
and three uninfected infants born to CMV-seropositive mothers). For each, DNA was isolated
from meconium by organic extraction and attachment to a DNA-binding matrix, and PCR was
performed using amplimers specific for the major intermediate early (MIE) and late antigenic (LA)
regions of CMV.
Results: Gel electrophoresis demonstrated an anticipated PCR product of 250 base pairs (bp)
corresponding to the MIE region ofCMV in all infected and positive control meconium samples.
Furthermore, a single band of 150 bp corresponding to the LA region ofCMV was also amplified
in several of the infected infants. Conversely, no amplification of these antigenic regions was noted
in either uninfected infants born to CMV-seropositive mothers or negative controls.
Conclusions:CMV is present within the meconium of infected neonates and is readily detectable
by PCR. Infect. Dis. Obstet. Gynecol. 8:166-171, 2000. (C) 2000Wiley-Liss, Inc.
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Ytomegalovirus (CMV) is the most common
congenital and perinatal viral infection
throughout the world, occurring in up to 3% of all
newborn infants. 1-3 It is the leading cause of sen-
sorineural hearing loss and the most frequently
known viral cause of mental retardation, z,3 Infec-
tion rates in pregnant women have been reported
to be as high as 50-80%. z,3 The vertical transmis-
sion rate of CMV is approximately 40% with pri-
mary infections and 0.2-1.8% with recurrent infec-
tions, z Although intrauterine infection is common,
only 10% of newborn infants will be symptomatic
at birth, with 5-15% of asymptomatic infants sub-
sequently demonstrating sensorineural hearing
loss, mental retardation, microcephaly or motor de-
fects by 2 years of age.2-4 Typical cytomegalic in-
clusion disease in symptomatic infants has a mor-
tality rate of 20-30%.
3
Cytomegalovirus is the largest member of the
Herpesviridae family, and it has the biological
properties of latency and reactivation. Its replica-
tive cycle is divided into an immediate early, early,
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and late antigenic period.4,s Infection with CMV is
currently diagnosed by viral cultures of the infant’s
urine or amniotic fluid or by measuring immuno-
globulin (Ig) M levels. Viral cultures require long
incubation times (from 1-2 weeks to as long as 6
weeks), and titer determinations may be of ques-
tionable sensitivity.4,6-8 Polymerase chain reaction
(PCR) is likely the most effective and sensitive
method to date for detecting the presence of the
virus.6,9-11 Polymerase chain reaction amplification
is currently used in the diagnosis of a humber of
intrauterine infections including herpes simplex vi-
rus, human immunodeficiency virus, and CMV.
Early detection of infection, while viral loads are
still low, enables the timely establishment of inter-
vention strategies such as antiviral therapy and
early parental counseling.7,1z-is To date, no studies
have utilized PCR to examine meconium for the
presence of pathogens. Fecal samples in general
have been one of the least studied clinical speci-
mens by PCR due to the presence of nonspecific
inhibitors, which interfere with the amplification
reaction. 16
Meconium consists of desquamated epithelial
cells from the intestine and skin, bile, pancreatic
secretions, and the residue of swallowed amniotic
fluid. Accumulation begins as early as the twelfth
gestational week, when fetal swallowing com-
mences. 17,1s Meconium may therefore serve as a
reservoir for viral and bacterial pathogens due to its
continuous exposure to the amniotic fluid and fetal
urine. 16 Meconium is a preferred specimen for
newborn drug screening since it can detect acute
and chronic fetal drug exposure from early midges-
tation to parturition.7,9 The ease of collection,
availability up to the third day of postnatal life, and
continual bioconcentration of meconium prompted
the development of a PCR-based methodology
that would enable the examination of meconium
for the presence of CMV.
METHODS
Collection of Meconium
Meconium samples used as controls and in spiking
experiments were collected from normal newborn
infants born to uninfected mothers. Meconium was
also collected from 10 newborn infants born to
CMV IgG-seropositive mothers. Seven of these in-
fants were diagnosed as CMV-positive by culture
(six by urine culture and one by amniotic fluid but
negative urine culture), and three infants had urine
cultures negative for CMV. The meconium was
stored at -70C until used. Sample collection was
conducted in accordance with guidelines estab-
lished by the institutional Human Investigation
Committee at the time these experiments were
conducted.
Extraction of DNA From Meconium
Meconium (0.05 g and 0.5 g) was dissolved in 10
volumes (w/vol) of Tris-HC1 buffer (pH 8.0) and
centrifuged at 2,000g for 10 minutes to remove par-
ticulate matter. Proteinase K (20 mg/mL) and so-
dium dodecyl sulfate (10%) were added to 500 pL
of the supernate and subsequently incubated in an
orbital shaker at 55C for 18 hours at 125 rpm. The
supernatants were extracted thrice with equal vol-
umes of chloroform:isoamyl alcohol:phenol (25:24:
1) and twice with equal volumes of isobutanol.
DNA was then absorbed to a DNA binding matrix
(Quantum Prep Plasmid miniprep kit, Bio-Rad
Laboratories, Hercules, CA) per manufacturers’ in-
structions and eluted from the matrix with two 50-
pL aliquots of sterile 50C water. The eluate was
subsequently stored at-20C until needed.
PCR Amplification of CMV DNA
The PCR amplification was conducted in a 50-pL
reaction volume containing Taq DNA polymerase
buffer (Promega Corporation, Madison, WI),
amplimers (1.0 mmol/L) from either the major in-
termediate early (MIE) region (5’-CCACCCGTG-
GTGCCAGCTCC-3’, 5’-CCCGCTCCTCCT-
GAGCACCC-3’) or the late antigenic (LA) region
(5’-CGGTTCAGGGTCAGAATCTG-3 ’, 5 ’-
CCATACGCCTTCCAATTCGG-3’) (Integrated
DNA Technologies, Inc., Coralville, IA) of CMV,
MgC1z (2.5 retool/L), dNTPs (0.2 mmol/L), and a
5.0-pL aliquot of the DNA-containing eluate,z
The PCR reaction mixture was subsequently over-
laid with 50 pL of sterile mineral oil (Sigma Chemi-
cal Co., St. Louis, MO). The template was initially
denatured for 5 minutes at 94C before the
addition of two units of Taq DNA polymerase
(Perkin-Elmer, Norwalk, CT). Amplification was
conducted in a Perkin-Elmer thermocycler
(Perkin-Elmer) for 40 cycles at a denaturation tem-
perature of 94C for 2 minutes, an annealing temp
of 65C for 90 seconds, and an extension tempera-
ture of 72C for 90 seconds. This was followed by
a terminal extension time of 10 minutes at 72C.
INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY 167PCR DETECTION OF CMV INMECONIUM VILLANUEVA ET AL.
636bp
576bp 532bp
468bp
343bp
211bp._.-
1 2 3 ,4 5
250 bp
Fig. I. Detection ofCMV MIE antigenic region from spiked meconium. PCR amplification yielded a 250-bp product from 0.05
g (lane I), 0.5 g (lane 2) of meconium spiked with 100 pL of CMV ADI69 stock culture and a PCR positive control (lane 4).
No product was amplified from either the negative meconium control, 0.5 g (lane 3), or the negative PCR control (lane 5).
The location of the amplified PCR product is indicated on the right.
The PCR products were subsequently resolved by
agarose gel electrophoresis. Amplimers to the MIE
and LA antigenic regions of the virus were used to
ensure detection of virtually all wild types of
CMV.e The positive meconium control consisted
of extracts from meconium (0.5 g) that was spiked
with 100 pL of heat-inactivated CMV strain AD169
stock culture. Positive PCR controls contained
CMV DNA isolated directly from the CMV AD169
stock culture. Negative meconium controls con-
tained meconium extracts from uninfected infants,
and negative PCR reactions had water substituted
for template DNA.
RESULTS
Detection of CMV From Spiked
Meconium Samples
Meconium (0.05 g, 0.5 g) spiked with 100 pL of
CMV AD169 stock culture yielded an anticipated
product of 250 base pairs (bp) following DNA ex-
traction and PCR amplification with the MIE am-
plimers of CMV (Fig. 1). A similar product was
obtained from the PCR positive control. Con-
versely, no amplification was obtained from either
the negative meconium or negative PCR control.
Detection of CMV in the Meconium of
Infected Infants
The PCR amplification using amplimers specific to
the MIE region of CMV yielded a 250-bp product
from six patients who had CMV-positive urine.
Amplification was also observed from the meco-
nium of one patient who was negative for CMV by
urine culture but had CMV-positive prenatal am-
niotic fluid by culture (Fig. 2). The PCR amplifi-
cation of the LA region of CMV yielded a 150-bp
product from three out of six patients with positive
urine cultures and the single patient with a nega-
tive urine culture but positive prenatal amniotic
fluid culture (Fig. 3). In both experiments PCR
products of 250 bp and 150 bp were amplified from
the CMV AD169 culture using the MIE and LA
amplimers, respectively. Conversely, no amplifica-
tion was observed in either the PCR or meconium-
negative controls.
The presence ofCMV in three culture-negative
patients born to CMV IgG-seropositive mothers
was also examined using amplimers to the MIE
and LA regions of CMV (Figs. 4, 5). In each in-
stance, PCR amplification failed to demonstrate
the presence of CMV in the meconium of infants
born to these CMV-infected mothers. Appropriate
PCR products of 25;0 bp and 150 bp were observed
following amplification of positive controls with
MIE and LA amplimers, respectively. No PCR
products were amplified from the negative meco-
nium or PCR controls.
DISCUSSION
The pathobiology ofCMV infection has been well
documented, but virtually nothing is known about
the appearance ofCMV or other pathogens in me-
conium, which was long considered to be a sterile
medium. The detection of pathogens in meconium
by PCR has been hindered by the presence of non-
specific inhibitors that preclude DNA amplifica-
tion. As a result, little is known about the ability of
meconium to serve either as a reservoir for infec-
tious agents acquired in utero or the utility of me-
conium to serve as a diagnostic specimen.
This report is the first to describe both the de-
tection of CMV in meconium and a methodology
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Fig. 2. Detection of the CMV MIE antigenic region in CMV-positive patients. Meconium from six neonatal patients with
CMV-positive urine (lanes I-6) and one patient with CMV-negative urine and CMV-positive amniotic fluid (lane 7) were
examined. PCR amplification yielded a 250-bp fragment in all patients examined and a positive PCR control (lane 8). No
product was amplified from the negative PCR control (lane 9).
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Fig. 3. Detection of the CMV LA antigenic region in CMV-positive patients. Meconium from six neonatal patients with
CMV-positive urine (lanes I-6) and one patient with CMV-negative urine and CMV-positive amniotic fluid (lane 7) were
examined. PCR amplification yielded a 150-bp fragment in four patients examined (lanes 3, 5, 6, 7) and a positive PCR control
(lane 8). No product was amplified from the negative PCR control (lane 9).
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Fig. 4. Detection of the CMV MIE antigenic region in CMV-negative neonatal patients born to CMV-positive mothers.
Meconium from three CMV-negative neonatal patients born to CMV-positive mothers was prepared for analysis by PCR. PCR
amplification failed to yield any product in either the patient samples (lanes I-3) or the negative meconium control (lane 6).
The positive PCR control yielded an anticipated product of 250 bp (lane 5).
that allows the isolation of relatively intact viral
DNA from meconium that is suitable for PCR am-
plification. The use ofPCR amplification following
organic extraction coupled with binding to a DNA
binding matrix enables the rapid and sensitive de-
tection of CMV in the meconium of newborn in-
fants infected in utero. The faster turnover time
(24-36 hours) as well as the use of very small
amounts of meconium are additional advantages of
this PCR strategy over conventional viral culture
techniques. Detection ofCMV by PCR from speci-
mens other than urine may provide important pre-
dictions for the development of systemic disease, el
For instance, performing PCR analysis and South-
ern hybridization on blood obtained from filter pa-
per utilized in newborn screening has revealed a
detection rate for CMV of 25% in healthy new-
borns and 33% in low-birthweight infants. These
rates are markedly higher than the known rate of
congenital CMV infection. 7 Likewise, PCR per-
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Fig. 5. Detection of the CMV LA antigenic region in CMV-negative neonatal patients born to CMV-positive mothers.
Meconium from three CMV-negative neonatal patients born to CMV-positive mothers was examined. PCR amplification failed
to yield any product in either the patient samples (lanes I-3) or the negative meconium control (lane 6). The positive PCR
control yielded an anticipated product of 150 bp (lane 5).
formed on chorionic villi revealed that 23% of all
samples tested positive for CMV. These findings
suggest both a higher transmission rate during early
pregnancy as well as an association with significant
fetal abnormalities or wastage. ",zl Meconium,
which begins forming early in gestation, may be a
better specimen than urine for the identification of
CMV infections that occurred early in pregnancy
because viral shedding in the urine may have
stopped at the time of birth.
With these data, we introduce an isolation strat-
egy that enables the detection and amplification of
CMV DNA from meconium. We have also demon-
strated the presence of CMV via PCR technology
in the meconium of infected neonates. The sensi-
tivity and specificity of this methodology will need
to be confirmed using a larger cohort of newborns.
Additionally, these comparisons must be made
against the accepted laboratory-based gold stan-
dards such as viral culture as well as against actual
clinical disease. Several limitations to this approach
are acknowledged. First, the possibility of neonatal
swallowing of contaminated maternal secretions
during delivery is a concern. In this regard, utilizing
a first-passage sample of meconium may be more
representative of the in utero environment. Fol-
lowing delivery, while contamination of meconium
with neonatal urine is possible, every precaution
was taken to avoid this in the samples collected. Of
note is the detection of CMV from a neonate with
a positive amniotic fluid culture but a negative
urine culture. Although PCR of the urine may have
yielded concordant results, the positive meconium
PCR in this case opens an interesting area of viro-
logic study. Does this represent digested debris in
a neonate exposed to but not infected with CMV?
Conversely, does this represent an early in utero
infection with systemic clearing of the virus? Un-
fortunately, neonatal serologic studies were not
available in this case to help differentiate these
possibilities. We hope that future studies with this
new approach, utilizing a readily available fetal by-
product (that serves as a reservoir for the in utero
environment throughout most of pregnancy), will
provide additional insight into the natural history of
this common fetal pathogen.
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